ENZN : Summary for ENZON PHARMACEUTIC COM USD0.01 - Yahoo Finance

U.S. Markets closed

Enzon Pharmaceuticals, Inc. (ENZN)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.33-0.01 (-2.08%)
At close: 3:42PM EST
People also watch
QLTIALKSPDLIMYGNIMMU
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.33
Open0.35
Bid0.00 x
Ask0.00 x
Day's Range0.33 - 0.35
52 Week Range0.31 - 0.56
Volume109,392
Avg. Volume224,419
Market Cap14.37M
Beta0.84
PE Ratio (TTM)0.90
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals
    GuruFocus.com3 months ago

    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals

    Activist investor continues his interest in penny stock

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube3 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated and Gilead Sciences, ... Read more (Read more...)

  • Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube6 months ago

    Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Enzon Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Enzon Pharmaceuticals, Inc. – Nektar Therapeutics, Enanta Pharmaceuticals, Inc., Amgen Inc., Merck & Co., Inc., XOMA Corporation, Bristol-Myers Squibb Company, Pfizer Inc., Vertex Pharmaceuticals Incorporated and ... Read more (Read more...)